| Dr Muhammad H Hawasli, MD | |
|
1136 Cleveland Ave, Ste 410, East Point, GA 30344-3618 | |
| (404) 766-0956 | |
| (404) 762-7922 |
| Full Name | Dr Muhammad H Hawasli |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 1136 Cleveland Ave, East Point, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316902018 | NPI | - | NPPES |
| 000425587C | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 023167 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Muhammad H Hawasli, MD 1136 Cleveland Ave, Ste 410, East Point, GA 30344-3618 Ph: (404) 766-0956 | Dr Muhammad H Hawasli, MD 1136 Cleveland Ave, Ste 410, East Point, GA 30344-3618 Ph: (404) 766-0956 |
News Archive
MILabs, B.V. the Netherlands‐based innovator and manufacturer of pre‐clinical SPECT/PET/CT imaging devices announces the release of the Plus! Systems: the U‐SPECT+ and U‐SPECT+ /CT.
The use of clot-busting drugs to clear blood from the brain's ventricles may be the first effective strategy to decrease mortality for a type of catastrophic bleeding stroke, according to phase-3 clinical trial results announced Thursday at the International Stroke Conference in Los Angeles.
People with "prediabetes" (a high risk state for overt type 2 diabetes) who experience a period of normal glucose regulation are 56% less likely to develop diabetes 5∙7 years later, according to a new research Article presented at the American Diabetes Association 72nd Scientific Sessions on Saturday 9 June, and published Online First in The Lancet. This is one of four Articles (all presented at the American Diabetes Association 72nd Scientific Sessions) and a Series of three papers that are part of a special Lancet theme issue on diabetes [1].
MitrAssist Medical Ltd., a developer of minimally invasive products for treating heart disease, announced today that it received ISO 13485:2003 Certification for the design and development of implantable heart valve prostheses.
› Verified 8 days ago
Dr. Yssa Saaddine, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1136 Cleveland Ave, Ste 209, East Point, GA 30344 Phone: 404-762-8211 Fax: 404-762-9182 | |
Charles N. Okolo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1151 Cleveland Ave, Suite D, East Point, GA 30344 Phone: 404-761-7949 Fax: 404-761-7386 | |
Dr. Legesse F. Tebeje, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1170 Cleveland Ave, East Point, GA 30344 Phone: 404-466-1170 | |
Austin Campbell Gitomer, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2084 Headland Dr, East Point, GA 30344 Phone: 404-965-5691 Fax: 404-698-1478 | |
Dr. Fawaz F Akbik, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1136 Cleveland Ave, Ste 519, East Point, GA 30344 Phone: 404-761-3525 Fax: 404-766-3696 | |
Enoch Kotei, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2084 Headland Dr, East Point, GA 30344 Phone: 404-965-5691 Fax: 404-698-1478 | |
Ngozika A Orjioke, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1136 Cleveland Ave Ste 615, East Point, GA 30344 Phone: 404-254-5388 Fax: 404-565-1255 |